<DOC>
	<DOC>NCT01025934</DOC>
	<brief_summary>The purpose of this study is to evaluate the role, the safety and the effectiveness of Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.</brief_summary>
	<brief_title>Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>vitreous haemorrhage tractional retinal detachment active proliferative diabetic retinopathy. neovascular glaucoma cataract combined traction and rhegmatogenous RD</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>